辻嘉代子 (KAYOKO TSUJI) - マイポータル

基本情報

所属: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター（臨床研究所）臨床研究所がん免疫療法研究開発学部

J-GLOBAL ID: 202401007613955160
researchmap会員ID: R000071304

論文

Tumor-reactive TCRs within exhausted TILs reveal cancer type-specific immune landscapes in renal cell carcinoma

Mitsuru Komahashi, Shun Horaguchi, Kayoko Tsuji, Daisuke Hoshino, Takeshi Kishida, Kimitsugu Usui, Noboru Nakaigawa, Shinya Sato, Hiroshi Hamana, Hiroyuki Kishi …

Frontiers in Immunology 17 2026年1月29日
Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer.

Yasunobu Mano, Yuka Igarashi, Keisuke Komori, Itaru Hashimoto, Hayato Watanabe, Kosuke Takahashi, Kazuki Kano, Hirohito Fujikawa, Takanobu Yamada, Hidetomo Himuro …

Frontiers in immunology 16 1521278-1521278 2025年
Machine learning-based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors.

Feifei Wei, Hiroyuki Takeda, Koichi Azuma, Yoshiro Nakahara, Yuka Igarashi, Kenta Murotani, Haruhiro Saito, Shuji Murakami, Tetsuro Kondo, Taku Kouro …

Frontiers in immunology 16 1666030-1666030 2025年
Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation.

Feifei Wei, Taku Kouro, Yuko Nakamura, Hiroki Ueda, Susumu Iiizumi, Kyoko Hasegawa, Yuki Asahina, Takeshi Kishida, Soichiro Morinaga, Hidetomo Himuro …

Computational and structural biotechnology journal 23 859-869 2024年12月
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Shun Horaguchi, Yoshiro Nakahara, Yuka Igarashi, Taku Kouro, Feifei Wei, Kenta Murotani, Seiichi Udagawa, Naoko Higashijima, Norikazu Matsuo, Shuji Murakami …

Biomedicines 12(8) 2024年8月12日
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.

Hidetomo Himuro, Yoshiro Nakahara, Yuka Igarashi, Taku Kouro, Naoko Higashijima, Norikazu Matsuo, Shuji Murakami, Feifei Wei, Shun Horaguchi, Kayoko Tsuji …

Cancer immunology, immunotherapy : CII 72(8) 2829-2840 2023年8月
Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures.

Feifei Wei, Koichi Azuma, Yoshiro Nakahara, Haruhiro Saito, Norikazu Matsuo, Tomoyuki Tagami, Taku Kouro, Yuka Igarashi, Takaaki Tokito, Terufumi Kato …

Journal for immunotherapy of cancer 11(7) 2023年7月
Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.

Yoshiro Nakahara, Taku Kouro, Satoru Motoyama, Masatomo Miura, Kazuma Fujita, Yuka Igarashi, Naoko Higashijima, Norikazu Matsuo, Hidetomo Himuro, Feifei Wei …

Frontiers in cell and developmental biology 11 1324898-1324898 2023年
[Current challenges and future perspectives of pharmacological testing using new approach methodologies].

Kayoko Tsuji, Ayano Satsuka, Yasunari Kanda

Nihon yakurigaku zasshi. Folia pharmacologica Japonica 156(4) 208-213 2021年
Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing.

Kayoko Tsuji, Shigeru Yamada, Kazuya Hirai, Hiroshi Asakura, Yasunari Kanda

The Journal of toxicological sciences 46(9) 425-435 2021年
Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow?

Stephanie M Jung, Mamiko Sonoda, Kayoko Tsuji, Atsuo Jimi, Shosaku Nomura, Taisuke Kanaji, Masaaki Moroi

Platelets 21(2) 101-11 2010年
Novel Approach for Formation of Platelet-like Particles from Mouse Embryonic Stem Cells without Using Feeder Cells

KAYOKO TSUJI, MASAAKI OHNUMA, STEPHANIE M. JUNG, MASAAKI MOROI

The Kurume Medical Journal 56(3/4) 61-69 2009年

共同研究・競争的資金等の研究課題

腫瘍浸潤T細胞とオルガノイドを用いた腎がん免疫病態の解明

日本学術振興会科学研究費助成事業基盤研究(C) 2023年4月 - 2026年3月

辻嘉代子
シングルセル解析による新たなTCR-T細胞作製法の検討ー個別化TCR-T細胞療法に向けて

日本学術振興会科学研究費助成事業基盤研究(C) 2023年4月 - 2026年3月

紅露拓, 辻嘉代子
iPS細胞を用いてのファブリ病、ポンペ病の病態解析並びに新規酵素補充療法の開発

日本学術振興会科学研究費助成事業基盤研究(C) 2014年4月 - 2017年3月

衞藤義勝, 藤崎美和, 柳澤比呂子, HOSSAIN ARIF, 辻嘉代子